Literature DB >> 24673885

Mechanism of action of the SPARI vilazodone: serotonin 1A partial agonist and reuptake inhibitor.

Stephen M Stahl.   

Abstract

ISSUE: Vilazodone is an antidepressant with a novel mechanism of pharmacologic action: serotonin partial agonist reuptake inhibitor (SPARI).

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24673885     DOI： 10.1017/S1092852914000169

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


  5 in total

1.  Neurochemical and behavioural effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake inhibitor and partial 5-HT1A agonist.

Authors:  Li-Ming Zhang; Xiao-Yun Wang; Nan Zhao; Yu-Lu Wang; Xiao-Xu Hu; Yu-Hua Ran; Yan-Qin Liu; You-Zhi Zhang; Ri-Fang Yang; Yun-Feng Li
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

Review 2.  Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice.

Authors:  Mohit Chauhan; Rebecca Parry; William V Bobo
Journal:  Neuropsychiatr Dis Treat       Date:  2022-06-14       Impact factor: 2.989

Review 3.  "Novel Psychopharmacology for Depressive Disorders".

Authors:  Michele Fornaro; Domenico De Berardis; Annalisa Anastasia; Andrea Fusco
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Vilazodone for the treatment of major depressive disorder: an evidence-based review of its place in therapy.

Authors:  David J Hellerstein; Joseph Flaxer
Journal:  Core Evid       Date:  2015-04-20

Review 5.  Vilazodone for the Treatment of Depression: An Update.

Authors:  Sheng-Min Wang; Changsu Han; Soo-Jung Lee; Ashwin A Patkar; Prakash S Masand; Chi-Un Pae
Journal:  Chonnam Med J       Date:  2016-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.